The first Law Update of 2024 is here, and our first focus of the year spotlights Healthcare and Lifesciences, a sector that is undergoing significant growth and development across the MENA region.
Our focus provides an insight into some of the most important regulatory updates across the region, such as the UAE’s groundbreaking law on the use of human genome, Kuwait’s resolution on nuclear and radioactive materials, the new regulations for healthcare services in Qatar, Egypt’s healthcare regulatory framework, and the impact of the Saudi Civil Transactions Law on the healthcare and life sciences sector … and there is so much more!
Beyond the healthcare pages our lawyers share with you multi-sector insights where you will discover articles on Dubai’s DIFC regulatory framework for startups, Bahrain’s commercial agencies law, and we also shed light on Kuwaiti civil code and the advantages of setting up a joint stock company in Saudi Arabia.Read the full edition
Pursuant to the Cabinet of Ministers Resolution No. 31 of 2019, the UAE has introduced economic substance regulations (“Regulations”) which set out the requirements for entities to have an actual economic presence in the UAE. The introduction of the Regulations follows the UAE’s commitment to comply with EU requirements in order to be removed from the EU’s list of non-cooperative tax jurisdictions (“EU Tax Blacklist”) .
The Regulations came into effect on 30 April 2019.
The key obligations imposed on UAE companies under the Regulations are as follows:
Failing to meet the Economic Substance Test:
Should a Licensee fail to meet the Economic Substance Test for a financial year, an administrative penalty of between AED 10,000 and AED 50,000 can be imposed by the Regulatory Authority. Repeated failure to meet the Economic Substance Test may lead to a penalty of up to AED 300,000.
Failing to provide information or providing inaccurate information:
Licensees who fail to provide information or provide inaccurate information under the Report may be subject to an administrative penalty of up to AED 50,000.
As the framework prescribed under the Regulations is of a high-level nature only, we expect:
It is important for your UAE businesses to (i) understand the economic substance requirements and the obligation to annually prepare the Report and file it with the Relevant Authority; and (ii) undertake a “health check” on your existing level of economic substance in the UAE.
The key areas of your operation that the Regulations may impact concern corporate structuring and tax aspects.
As the largest law firm in the Middle East and with strong corporate structuring and tax expertise and significant corporate structuring and tax experience across all industry sectors in the Middle East, Al Tamimi & Company is well placed to assess the impact of the recently introduced Regulations on your organisation and assist you to comply with the new Regulations.
Click here to follow Al Tamimi’s Tax Team’s LinkedIn page for more updates on tax developments in the Middle East.